In murine models, the absence of IRF4 has been proven to exacerbate the progression of myeloid leukemia [28], reinforcing the essential role of IRF4 in blood disorders and presenting potential avenues for disease intervention and treatment. The gene discussed is IRF4; the disease is hematologic disorder.